Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ATP-dependent activity	MYH10 ABCF3 ATP7B ABCA12 MYH7B KIF16B RNF213 DNAH14 MSH6 MFSD2A DDX50 MYH14 ENTPD1 NAV1 ACSM5 MYH15 TAP1	1.75e-05	614	168	17	GO:0140657
GeneOntologyMolecularFunction	phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity	TPTE2 PTEN	7.04e-05	2	168	2	GO:0051800
GeneOntologyMolecularFunction	voltage-gated chloride channel activity	CLCN3 CLCN5 ANO6	9.19e-05	11	168	3	GO:0005247
GeneOntologyMolecularFunction	microfilament motor activity	MYH10 MYH7B MYH14 MYH15	2.85e-04	38	168	4	GO:0000146
GeneOntologyMolecularFunction	voltage-gated monoatomic anion channel activity	CLCN3 CLCN5 ANO6	3.65e-04	17	168	3	GO:0008308
GeneOntologyMolecularFunction	phosphatidylinositol-3,4-bisphosphate phosphatase activity	TPTE2 PTEN	4.18e-04	4	168	2	GO:0106017
GeneOntologyMolecularFunction	phosphoric ester hydrolase activity	RNGTT TPTE2 PTEN PPEF1 PPM1H SMPDL3B PLCL2 NT5C2 PLCB4 PLCG1 SSH2	4.40e-04	386	168	11	GO:0042578
GeneOntologyMolecularFunction	cytoskeletal motor activity	MYH10 MYH7B KIF16B DNAH14 MYH14 MYH15	4.91e-04	118	168	6	GO:0003774
GeneOntologyMolecularFunction	acetylglucosaminyltransferase activity	MGAT4B B4GAT1 B3GNT6 MGAT1	6.50e-04	47	168	4	GO:0008375
GeneOntologyMolecularFunction	phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity	TPTE2 PTEN	6.92e-04	5	168	2	GO:0016314
GeneOntologyMolecularFunction	ADP binding	MYH10 MSH6 MIEF1 TAP1	7.05e-04	48	168	4	GO:0043531
GeneOntologyMolecularFunction	voltage-gated monoatomic ion channel activity	TPCN2 LRRC38 GRIN2D KCNA2 CLCN3 CLCN5 ANO6	8.97e-04	182	168	7	GO:0005244
GeneOntologyMolecularFunction	catalytic activity, acting on a glycoprotein	MGAT4B B3GNT6 MGAT1	9.15e-04	23	168	3	GO:0140103
GeneOntologyMolecularFunction	voltage-gated channel activity	TPCN2 LRRC38 GRIN2D KCNA2 CLCN3 CLCN5 ANO6	9.57e-04	184	168	7	GO:0022832
GeneOntologyMolecularFunction	mRNA 5'-UTR binding	MYH10 UTP23 GNL3	1.17e-03	25	168	3	GO:0048027
GeneOntologyMolecularFunction	hydrolase activity, acting on ester bonds	RNGTT TPTE2 PTEN ERN2 PPEF1 PLBD2 PPM1H SMPDL3B PLCL2 INTS11 NT5C2 PARN PLCB4 PLCG1 SSH2 VARS1	1.32e-03	807	168	16	GO:0016788
GeneOntologyMolecularFunction	phosphatidylinositol phospholipase C activity	PLCL2 PLCB4 PLCG1	1.32e-03	26	168	3	GO:0004435
GeneOntologyCellularComponent	myosin filament	MYH10 MYH7B MYH14 MYH15	4.46e-05	25	168	4	GO:0032982
GeneOntologyCellularComponent	myosin II complex	MYH10 MYH7B MYH14 MYH15	7.09e-05	28	168	4	GO:0016460
GeneOntologyCellularComponent	myosin II filament	MYH10 MYH14	1.92e-04	3	168	2	GO:0097513
Domain	Myosin_N	MYH10 MYH7B MYH14 MYH15	7.98e-06	15	168	4	PF02736
Domain	Myosin_N	MYH10 MYH7B MYH14 MYH15	7.98e-06	15	168	4	IPR004009
Domain	Myosin_tail_1	MYH10 MYH7B MYH14 MYH15	1.75e-05	18	168	4	PF01576
Domain	Myosin_tail	MYH10 MYH7B MYH14 MYH15	1.75e-05	18	168	4	IPR002928
Domain	C2_dom	CPNE8 CPNE9 TPTE2 PTEN PLCL2 CPNE1 CC2D2A PLCB4 PLCG1	1.79e-05	164	168	9	IPR000008
Domain	Myosin-like_IQ_dom	MYH10 MYH7B MYH14 MYH15	2.20e-05	19	168	4	IPR027401
Domain	-	MYH10 MYH7B MYH14 MYH15	2.20e-05	19	168	4	4.10.270.10
Domain	Copine	CPNE8 CPNE9 CPNE1	5.77e-05	9	168	3	PF07002
Domain	Copine	CPNE8 CPNE9 CPNE1	5.77e-05	9	168	3	IPR010734
Domain	Vitellinogen_b-sht_N	APOB MTTP	8.04e-05	2	168	2	IPR015816
Domain	Lipid_transp_b-sht_shell	APOB MTTP	8.04e-05	2	168	2	IPR015819
Domain	-	APOB MTTP	8.04e-05	2	168	2	2.30.230.10
Domain	VITELLOGENIN	APOB MTTP	8.04e-05	2	168	2	PS51211
Domain	LPD_N	APOB MTTP	8.04e-05	2	168	2	SM00638
Domain	Lipid_transpt_N	APOB MTTP	8.04e-05	2	168	2	IPR001747
Domain	-	APOB MTTP	8.04e-05	2	168	2	1.25.10.20
Domain	Vitellogenin_N	APOB MTTP	8.04e-05	2	168	2	PF01347
Domain	An_peroxidase	MPO EPX PTGS1	8.19e-05	10	168	3	PF03098
Domain	Haem_peroxidase_animal	MPO EPX PTGS1	8.19e-05	10	168	3	IPR019791
Domain	Haem_peroxidase	MPO EPX PTGS1	8.19e-05	10	168	3	IPR010255
Domain	PEROXIDASE_3	MPO EPX PTGS1	8.19e-05	10	168	3	PS50292
Domain	-	MPO EPX PTGS1	8.19e-05	10	168	3	1.10.640.10
Domain	VWFA	COL6A3 CPNE8 CPNE9 ITGB2 ITGB7 CPNE1	9.64e-05	82	168	6	PS50234
Domain	EGF_1	LAMA2 MUC12 LRP1B ITGB2 PTGS1 ITGB7 CELSR1 TENM4 NRXN2 TNXB	1.07e-04	255	168	10	PS00022
Domain	VWA	COL6A3 CPNE8 CPNE9 ITGB2 ITGB7 CPNE1	1.10e-04	84	168	6	SM00327
Domain	EGF-like_CS	LAMA2 MUC12 LRP1B ITGB2 PTGS1 ITGB7 CELSR1 TENM4 NRXN2 TNXB	1.30e-04	261	168	10	IPR013032
Domain	EGF_2	LAMA2 MUC12 LRP1B ITGB2 PTGS1 ITGB7 CELSR1 TENM4 NRXN2 TNXB	1.47e-04	265	168	10	PS01186
Domain	C2	CPNE8 CPNE9 PLCL2 CPNE1 CC2D2A PLCB4 PLCG1	1.84e-04	131	168	7	PF00168
Domain	EGF_extracell	LRP1B ITGB2 ITGB7 TENM4 TNXB	2.03e-04	60	168	5	IPR013111
Domain	EGF_2	LRP1B ITGB2 ITGB7 TENM4 TNXB	2.03e-04	60	168	5	PF07974
Domain	P-loop_NTPase	MYH10 ABCF3 ABCA12 MYH7B KIF16B RNF213 UST DNAH14 MSH6 DDX50 CHST15 MYH14 NAV1 MYH15 TAP1 NLRP4 GNL3 MX1 RASD2	2.31e-04	848	168	19	IPR027417
Domain	Vitellinogen_superhlx	APOB MTTP	2.40e-04	3	168	2	IPR011030
Domain	C2	CPNE8 CPNE9 PLCL2 CPNE1 CC2D2A PLCB4 PLCG1	2.43e-04	137	168	7	SM00239
Domain	VWF_A	COL6A3 CPNE8 CPNE9 ITGB2 ITGB7 CPNE1	2.72e-04	99	168	6	IPR002035
Domain	EF-hand_like	PLCL2 PLCB4 PLCG1	3.00e-04	15	168	3	PF09279
Domain	PI-PLC-Y	PLCL2 PLCB4 PLCG1	3.00e-04	15	168	3	PF00387
Domain	PLCYc	PLCL2 PLCB4 PLCG1	3.00e-04	15	168	3	SM00149
Domain	PLipase_C_Pinositol-sp_Y	PLCL2 PLCB4 PLCG1	3.00e-04	15	168	3	IPR001711
Domain	PIPLC_Y_DOMAIN	PLCL2 PLCB4 PLCG1	3.00e-04	15	168	3	PS50008
Domain	PI-PLC_fam	PLCL2 PLCB4 PLCG1	3.00e-04	15	168	3	IPR001192
Domain	PLC_EF-hand-like	PLCL2 PLCB4 PLCG1	3.00e-04	15	168	3	IPR015359
Domain	C2	CPNE8 CPNE9 PLCL2 CPNE1 CC2D2A PLCB4 PLCG1	3.02e-04	142	168	7	PS50004
Domain	Myosin_head_motor_dom	MYH10 MYH7B MYH14 MYH15	3.67e-04	38	168	4	IPR001609
Domain	MYOSIN_MOTOR	MYH10 MYH7B MYH14 MYH15	3.67e-04	38	168	4	PS51456
Domain	Myosin_head	MYH10 MYH7B MYH14 MYH15	3.67e-04	38	168	4	PF00063
Domain	MYSc	MYH10 MYH7B MYH14 MYH15	3.67e-04	38	168	4	SM00242
Domain	-	CPNE8 CPNE9 PLCL2 CPNE1 CC2D2A PLCB4 PLCG1	3.88e-04	148	168	7	2.60.40.150
Domain	PPR	DENND4A PTCD1	4.77e-04	4	168	2	PF01535
Domain	Dual-sp_phosphatase_cat-dom	RNGTT TPTE2 PTEN SSH2	4.93e-04	41	168	4	IPR000340
Domain	DSPc	RNGTT TPTE2 PTEN SSH2	4.93e-04	41	168	4	PF00782
Domain	PI-PLC-X	PLCL2 PLCB4 PLCG1	5.28e-04	18	168	3	PF00388
Domain	PLCXc	PLCL2 PLCB4 PLCG1	5.28e-04	18	168	3	SM00148
Domain	aa-tRNA-synth_II	EPRS1 KARS1 EIF2AK4	5.28e-04	18	168	3	IPR006195
Domain	AA_TRNA_LIGASE_II	EPRS1 KARS1 EIF2AK4	5.28e-04	18	168	3	PS50862
Domain	PIPLC_X_DOMAIN	PLCL2 PLCB4 PLCG1	6.23e-04	19	168	3	PS50007
Domain	PLipase_C_PInositol-sp_X_dom	PLCL2 PLCB4 PLCG1	6.23e-04	19	168	3	IPR000909
Domain	IQ	MYH10 MYH7B PPEF1 MYH14 SCN7A	8.19e-04	81	168	5	SM00015
Domain	Integrin_b_cyt	ITGB2 ITGB7	1.18e-03	6	168	2	SM01241
Domain	Integrin_b_cyt	ITGB2 ITGB7	1.18e-03	6	168	2	PF08725
Domain	PEROXIDASE_1	MPO EPX	1.18e-03	6	168	2	PS00435
Domain	Integrin_bsu_cyt_dom	ITGB2 ITGB7	1.18e-03	6	168	2	IPR014836
Domain	IQ_motif_EF-hand-BS	MYH10 MYH7B PPEF1 MYH14 SCN7A	1.32e-03	90	168	5	IPR000048
Domain	-	PLCL2 PLCB4 PLCG1	1.42e-03	25	168	3	3.20.20.190
Domain	PLC-like_Pdiesterase_TIM-brl	PLCL2 PLCB4 PLCG1	1.42e-03	25	168	3	IPR017946
Domain	IQ	MYH10 MYH7B PPEF1 MYH14 MYH15	1.52e-03	93	168	5	PS50096
Domain	Plectin	PPL PLEC	1.64e-03	7	168	2	PF00681
Domain	Integrin_B_tail	ITGB2 ITGB7	1.64e-03	7	168	2	SM01242
Domain	Plectin_repeat	PPL PLEC	1.64e-03	7	168	2	IPR001101
Domain	Integrin_bsu_tail	ITGB2 ITGB7	1.64e-03	7	168	2	IPR012896
Domain	Integrin_B_tail	ITGB2 ITGB7	1.64e-03	7	168	2	PF07965
Domain	PLEC	PPL PLEC	1.64e-03	7	168	2	SM00250
Domain	Channel_four-helix_dom	TPCN2 TPTE2 KCNA2 SCN7A	1.72e-03	57	168	4	IPR027359
Domain	-	TPCN2 TPTE2 KCNA2 SCN7A	1.72e-03	57	168	4	1.20.120.350
Domain	IPT	REL EBF1 PLXNA2	1.78e-03	27	168	3	SM00429
Domain	Prot-tyrosine_phosphatase-like	RNGTT TPTE2 PTEN MTMR11 SSH2	2.01e-03	99	168	5	IPR029021
Domain	PTEN_C2	TPTE2 PTEN	2.17e-03	8	168	2	PF10409
Domain	INB	ITGB2 ITGB7	2.17e-03	8	168	2	SM00187
Domain	Integrin_bsu_VWA	ITGB2 ITGB7	2.17e-03	8	168	2	IPR002369
Domain	PTEN_C2	TPTE2 PTEN	2.17e-03	8	168	2	SM01326
Domain	C2_TENSIN	TPTE2 PTEN	2.17e-03	8	168	2	PS51182
Domain	Integrin_beta	ITGB2 ITGB7	2.17e-03	8	168	2	PF00362
Domain	Tensin_lipid_phosphatase_dom	TPTE2 PTEN	2.17e-03	8	168	2	IPR029023
Domain	PPR	DENND4A PTCD1	2.17e-03	8	168	2	PS51375
Domain	Tensin_C2-dom	TPTE2 PTEN	2.17e-03	8	168	2	IPR014020
Domain	Ig_E-set	REL EBF1 UNC119 ARRDC3 PLXNA2	2.49e-03	104	168	5	IPR014756
Domain	TIG	REL EBF1 PLXNA2	2.67e-03	31	168	3	PF01833
Domain	Cl-channel_core	CLCN3 CLCN5	2.78e-03	9	168	2	IPR014743
Domain	Integrin_bsu	ITGB2 ITGB7	2.78e-03	9	168	2	IPR015812
Domain	-	CLCN3 CLCN5	2.78e-03	9	168	2	1.10.3080.10
Domain	Voltage_CLC	CLCN3 CLCN5	2.78e-03	9	168	2	PF00654
Domain	Cl-channel_volt-gated	CLCN3 CLCN5	2.78e-03	9	168	2	IPR001807
Domain	INTEGRIN_BETA	ITGB2 ITGB7	2.78e-03	9	168	2	PS00243
Domain	PSI_integrin	ITGB2 ITGB7	2.78e-03	9	168	2	PF17205
Domain	PPASE_TENSIN	TPTE2 PTEN	2.78e-03	9	168	2	PS51181
Domain	Integin_beta_N	ITGB2 ITGB7	2.78e-03	9	168	2	IPR033760
Domain	IPT	REL EBF1 PLXNA2	2.93e-03	32	168	3	IPR002909
Domain	Ion_trans_dom	TPCN2 TPTE2 RYR2 KCNA2 SCN7A	3.70e-03	114	168	5	IPR005821
Domain	Ion_trans	TPCN2 TPTE2 RYR2 KCNA2 SCN7A	3.70e-03	114	168	5	PF00520
Pathway	KEGG_VIRAL_MYOCARDITIS	MYH10 MYH7B LAMA2 ITGB2 MYH14 MYH15	2.96e-05	70	121	6	M12294
Pathway	WP_PHOSPHOINOSITIDES_METABOLISM	PTEN PIK3R4 MTMR11 PLCB4 PLCG1	6.05e-05	49	121	5	M40046
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	KRT1 EPRS1 DENND4A MYH10 PCDHGC5 MYH7B ADAM7 REL APOB ST3GAL2 EPX PPL RYR2 CLCN3 CLCN5 DDX50 ZBED4 MYH14 VPS13A MTTP CC2D2A MYH15 EIF2AK4 PLEC VARS1 PLXNA2	9.53e-09	1442	170	26	35575683
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	RELCH MYH10 RNGTT TPTE2 POLR2B SHMT2 RNF213 PTEN PPEF1 PPM1H CEMIP2 MSH6 MTMR11 KARS1 DDX50 PLCL2 INTS11 VPS13A EIF2AK4 SSH2 HERC1	5.10e-08	1049	170	21	27880917
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	KRT1 EPRS1 CPNE8 MYH10 ACACA MSH6 MYH14 MTTP EIF2AK4 PLEC	6.62e-08	202	170	10	33005030
Pubmed	Phosphatase and tensin homolog (PTEN) regulates hepatic lipogenesis, microsomal triglyceride transfer protein, and the secretion of apolipoprotein B-containing lipoproteins.	APOB PTEN MTTP	1.15e-07	3	170	3	19026012
Pubmed	Biochemical characterization of copine: a ubiquitous Ca2+-dependent, phospholipid-binding protein.	CPNE8 CPNE9 CPNE1	1.15e-07	3	170	3	11123945
Pubmed	Defining the membrane proteome of NK cells.	KRT1 EPRS1 ABCF3 ATP7B ERO1A DOCK9 RNF213 ITGB2 ITGB7 PIK3R4 MGAT1 CLCN3 CLCN5 DDX50 SLC16A1 MYH14 ANO6 ENTPD1 LPGAT1 TAP1 GNL3	3.03e-07	1168	170	21	19946888
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	KRT1 MYH10 WDR7 POLR2B ZMYND8 SHMT2 ZSCAN25 MSH6 KARS1 DDX50 ZBED4 NRXN2 SLC16A1 CFAP20 INTS11 CPNE1 TAF5L PLEC TNXB VARS1	3.85e-07	1082	170	20	38697112
Pubmed	Evolutionary implications of three novel members of the human sarcomeric myosin heavy chain gene family.	MYH7B MYH14 MYH15	4.57e-07	4	170	3	11919279
Pubmed	Rap1-mediated lymphocyte function-associated antigen-1 activation by the T cell antigen receptor is dependent on phospholipase C-gamma1.	ITGB2 PLCG1 RASGRP2	4.57e-07	4	170	3	14702343
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	MYH10 WDR7 DOCK9 TENM4 ZBED4 CHST15 PLCL2 NAV1 DISP2 ARRDC3 PLXNA2 ARAP2	8.72e-07	407	170	12	12693553
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	PRRG1 EPRS1 ABCF3 TAGAP ERO1A DOCK9 POLR2B SHMT2 APOB ST3GAL2 DDX50 PTCD1 PLCL2 ADAMTS18 EIF2AK4 PLCG1 PLEC HERC1 NLRP4	1.68e-06	1084	170	19	11544199
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	MGAT4B ACACA DOCK9 GRIN2D UNC119 CELSR1 MGAT1 ZBED4 CHST15 PITX1 TMEM132A INTS11 ZNF500 NAV1 DISP2 PLCG1 PLEC HERC1 RASD2	2.22e-06	1105	170	19	35748872
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	COG2 MYH10 ACACA OR2G6 POLR2B SHMT2 MUC12 MSH6 MFSD2A VPS52 PIGC ZBED4 SLC16A1 CFAP20 NT5C2 PARN EIF2AK4 PLCG1 TAF5L SSH2 ZMYM4	2.32e-06	1327	170	21	32694731
Pubmed	USP45 and Spindly are part of the same complex implicated in cell migration.	EPRS1 CPNE8 MYH10 CTTNBP2 CPNE9 POLR2B MSH6 MYH14 PLEC	2.59e-06	235	170	9	30258100
Pubmed	High throughput RNAi screening identifies ID1 as a synthetic sick/lethal gene interacting with the common TP53 mutation R175H.	TPCN2 ABCA12 CPN1 ITGB7 PTCD1	4.21e-06	49	170	5	24378760
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	KRT1 RNGTT ACACA WDR7 RNF213 APOB PPL RYR2 CEMIP2 VPS52 DDX50 ANO6 VPS13A MIEF1 ARAP2	7.12e-06	777	170	15	35844135
Pubmed	Proteome analysis of the circadian clock protein PERIOD2.	CPNE8 CPNE9 ACACA ERO1A MYH14 PLEC	7.12e-06	94	170	6	35122331
Pubmed	The copines, a novel class of C2 domain-containing, calcium-dependent, phospholipid-binding proteins conserved from Paramecium to humans.	CPNE8 CPNE9 CPNE1	9.43e-06	9	170	3	9430674
Pubmed	METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis.	COL6A3 MYH10 ACACA SLC16A1 MYH14 HERC1 VARS1 GNL3	1.95e-05	231	170	8	36597993
Pubmed	In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.	MPO KRT1 COL6A3 CPNE8 MYH10 CPNE9 B4GAT1 APOB EPX PLBD2 LGALS3BP MGAT1 SMPDL3B ANO6 TMEM132A CPNE1 TNXB	2.16e-05	1070	170	17	23533145
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	EPRS1 DENND4A MYH10 ACACA ERO1A POLR2B SHMT2 APOB PIK3R4 MSH6 KARS1 DDX50 SLC16A1 MYH14 INTS11 CC2D2A PLCG1 TAF5L VARS1 GNL3	2.35e-05	1425	170	20	30948266
Pubmed	Uncovering a new role for peroxidase enzymes as drivers of angiogenesis.	MPO EPX	2.38e-05	2	170	2	26386352
Pubmed	Truncated human betaB1-crystallin shows altered structural properties and interaction with human betaA3-crystallin.	CRYBA1 CRYBB1	2.38e-05	2	170	2	19548648
Pubmed	Pathological changes in levels of three small stress proteins, alphaB crystallin, HSP 27 and p20, in the hindlimb muscles of dy mouse.	LAMA2 CRYBA1	2.38e-05	2	170	2	9573353
Pubmed	Human placenta secretes apolipoprotein B-100-containing lipoproteins.	APOB MTTP	2.38e-05	2	170	2	15504742
Pubmed	Translational study of the whole transcriptome in rats and genetic polymorphisms in humans identifies LRP1B and VPS13A as key genes involved in tolerance to cocaine-induced motor disturbances.	LRP1B VPS13A	2.38e-05	2	170	2	33159041
Pubmed	Association properties of betaB1- and betaA3-crystallins: ability to form heterotetramers.	CRYBA1 CRYBB1	2.38e-05	2	170	2	18823128
Pubmed	Inflammatory peroxidases promote breast cancer progression in mice via regulation of the tumour microenvironment.	MPO EPX	2.38e-05	2	170	2	28260049
Pubmed	COL6A and LAMA2 Mutation Congenital Muscular Dystrophy: A Clinical and Electrophysiological Study.	COL6A3 LAMA2	2.38e-05	2	170	2	29465610
Pubmed	Microsomal triglyceride transfer protein gene expression and ApoB secretion are inhibited by bitter melon in HepG2 cells.	APOB MTTP	2.38e-05	2	170	2	15795421
Pubmed	A deficiency of microsomal triglyceride transfer protein reduces apolipoprotein B secretion.	APOB MTTP	2.38e-05	2	170	2	10713055
Pubmed	Myosin II isoform switching mediates invasiveness after TGF-β-induced epithelial-mesenchymal transition.	MYH10 MYH14	2.38e-05	2	170	2	22025714
Pubmed	Homozygous MTTP and APOB mutations may lead to hepatic steatosis and fibrosis despite metabolic differences in congenital hypocholesterolemia.	APOB MTTP	2.38e-05	2	170	2	24842304
Pubmed	β2 integrin-mediated cell-cell contact transfers active myeloperoxidase from neutrophils to endothelial cells.	MPO ITGB2	2.38e-05	2	170	2	23532856
Pubmed	Microsomal triglyceride transfer protein binding and lipid transfer activities are independent of each other, but both are required for secretion of apolipoprotein B lipoproteins from liver cells.	APOB MTTP	2.38e-05	2	170	2	11358959
Pubmed	Hereditary eosinophil peroxidase deficiency: immunochemical and spectroscopic studies and evidence for a compound heterozygosity of the defect.	MPO EPX	2.38e-05	2	170	2	7809065
Pubmed	Cytolinker cross-talk: periplakin N-terminus interacts with plectin to regulate keratin organisation and epithelial migration.	PPL PLEC	2.38e-05	2	170	2	17662978
Pubmed	The role of PTEN in the progression and survival of prostate cancer.	TPTE2 PTEN	2.38e-05	2	170	2	12717346
Pubmed	Structure-function analyses of microsomal triglyceride transfer protein missense mutations in abetalipoproteinemia and hypobetalipoproteinemia subjects.	APOB MTTP	2.38e-05	2	170	2	27487388
Pubmed	Identification of patients with abetalipoproteinemia and homozygous familial hypobetalipoproteinemia in Tunisia.	APOB MTTP	2.38e-05	2	170	2	19056372
Pubmed	Oxidative modifications of extracellular matrix promote the second wave of inflammation via β2 integrins.	MPO ITGB2	2.38e-05	2	170	2	29724896
Pubmed	Relationship between Amphipathic β Structures in the β1 Domain of Apolipoprotein B and the Properties of the Secreted Lipoprotein Particles in McA-RH7777 Cells.	APOB MTTP	2.38e-05	2	170	2	28702990
Pubmed	A genetic linkage map of 27 markers on human chromosome 21.	ITGB2 MX1	2.38e-05	2	170	2	1674496
Pubmed	Peroxidase enzymes inhibit osteoclast differentiation and bone resorption.	MPO EPX	2.38e-05	2	170	2	27836774
Pubmed	Transcription factor EBF1 mitigates neuropathic pain by rescuing Kv1.2 expression in primary sensory neurons.	EBF1 KCNA2	2.38e-05	2	170	2	37607607
Pubmed	A common binding site on the microsomal triglyceride transfer protein for apolipoprotein B and protein disulfide isomerase.	APOB MTTP	2.38e-05	2	170	2	9915855
Pubmed	Chloride/proton antiporters ClC3 and ClC5 support bone formation in mice.	CLCN3 CLCN5	2.38e-05	2	170	2	38666049
Pubmed	Laminin stimulates and guides axonal outgrowth via growth cone myosin II activity.	MYH10 MYH14	2.38e-05	2	170	2	15880105
Pubmed	Novel mutations in abetalipoproteinaemia and homozygous familial hypobetalipoproteinaemia.	APOB MTTP	2.38e-05	2	170	2	18027103
Pubmed	The benefits of being β-crystallin heteromers: βB1-crystallin protects βA3-crystallin against aggregation during co-refolding.	CRYBA1 CRYBB1	2.38e-05	2	170	2	22032798
Pubmed	α-Mannosidase 2C1 attenuates PTEN function in prostate cancer cells.	MAN2C1 PTEN	2.38e-05	2	170	2	21556061
Pubmed	Hypobetalipoproteinemia with an apparently recessive inheritance due to a "de novo" mutation of apolipoprotein B.	APOB MTTP	2.38e-05	2	170	2	14732481
Pubmed	MCT-1 expression and PTEN deficiency synergistically promote neoplastic multinucleation through the Src/p190B signaling activation.	PTEN SLC16A1	2.38e-05	2	170	2	24858043
Pubmed	Ablation of nonmuscle myosin II-B and II-C reveals a role for nonmuscle myosin II in cardiac myocyte karyokinesis.	MYH10 MYH14	2.38e-05	2	170	2	20861308
Pubmed	Microsomal triglyceride transfer protein activity is not required for the initiation of apolipoprotein B-containing lipoprotein assembly in McA-RH7777 cells.	APOB MTTP	2.38e-05	2	170	2	17690102
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	MGAT4B B4GAT1 FKRP ERO1A RNF213 ST3GAL2 LRP1B UST PLBD2 PTGS1 CEMIP2 LGALS3BP CELSR1 ANO6 TMEM132A RNFT1 LPGAT1 TAP1	2.64e-05	1201	170	18	35696571
Pubmed	Kelch Domain of Gigaxonin Interacts with Intermediate Filament Proteins Affected in Giant Axonal Neuropathy.	KRT1 COL6A3 RNF213 EPX MYH14 SSH2 PLEC	3.99e-05	187	170	7	26460568
Pubmed	Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.	MPO COL6A3 CPNE9 LAMA2 APOB ITGB2 LGALS3BP TNXB	4.17e-05	257	170	8	16335952
Pubmed	Tagging genes with cassette-exchange sites.	RELCH WDR7 DOCK9 POLR2B ZMYND8 TAF5L PLEC GNL3 ZMYM4	4.35e-05	335	170	9	15741177
Pubmed	The DNA sequence and comparative analysis of human chromosome 20.	MYH7B OGFR ZMYND8 KIF16B SCAND1 SSTR4 CCN5 CDH22 CPNE1 PLCB4 PLCG1	5.21e-05	517	170	11	11780052
Pubmed	Proteomic identification of common SCF ubiquitin ligase FBXO6-interacting glycoproteins in three kinds of cells.	EPRS1 ABCF3 ACACA B4GAT1 ERO1A POLR2B PLBD2 PTGS1 CEMIP2 LGALS3BP KARS1 VARS1	5.29e-05	613	170	12	22268729
Pubmed	A new role for the architecture of microvillar actin bundles in apical retention of membrane proteins.	MYH10 LCTL MYH14 PLEC	7.02e-05	45	170	4	22114352
Pubmed	Polymorphisms in the estrogen receptor 1 and vitamin C and matrix metalloproteinase gene families are associated with susceptibility to lymphoma.	MPO PARG SHMT2 APOB ITGB2 PTGS1	7.09e-05	141	170	6	18636124
Pubmed	PCAF modulates PTEN activity.	PTEN TAF5L	7.10e-05	3	170	2	16829519
Pubmed	The potential for repositioning antithyroid agents as antiasthma drugs.	MPO EPX	7.10e-05	3	170	2	27444178
Pubmed	Deamidation alters interactions of beta-crystallins in hetero-oligomers.	CRYBA1 CRYBB1	7.10e-05	3	170	2	19190732
Pubmed	Planar polarity of multiciliated ependymal cells involves the anterior migration of basal bodies regulated by non-muscle myosin II.	MYH10 MYH14	7.10e-05	3	170	2	20685736
Pubmed	Peroxidasin and eosinophil peroxidase, but not myeloperoxidase, contribute to renal fibrosis in the murine unilateral ureteral obstruction model.	MPO EPX	7.10e-05	3	170	2	30565999
Pubmed	Microsomal triglyceride transfer protein enhances cellular cholesteryl esterification by relieving product inhibition.	APOB MTTP	7.10e-05	3	170	2	18502767
Pubmed	Coding region polyadenylation generates a truncated tRNA synthetase that counters translation repression.	EPRS1 KARS1	7.10e-05	3	170	2	22386318
Pubmed	The evolutionary conservation of the mammalian peroxidase genes.	MPO EPX	7.10e-05	3	170	2	12584448
Pubmed	Correlation between the clinical phenotype of MYH9-related disease and tissue distribution of class II nonmuscle myosin heavy chains.	MYH10 MYH14	7.10e-05	3	170	2	15177565
Pubmed	Myosin IIA suppresses glioblastoma development in a mechanically sensitive manner.	MYH10 PTEN	7.10e-05	3	170	2	31235578
Pubmed	Diabetes adversely affects macrophages during atherosclerotic plaque regression in mice.	APOB MTTP	7.10e-05	3	170	2	21562077
Pubmed	Primary phospholipase C and brain disorders.	PLCB4 PLCG1	7.10e-05	3	170	2	26639088
Pubmed	Support of bone mineral deposition by regulation of pH.	CLCN3 CLCN5	7.10e-05	3	170	2	30044661
Pubmed	Secretion of atherogenic risk factor apolipoprotein B-100 is increased by a potential mechanism of JNK/PKC-mediated insulin resistance in liver cells.	APOB MTTP	7.10e-05	3	170	2	17647275
Pubmed	Novel Abetalipoproteinemia Missense Mutation Highlights the Importance of the N-Terminal β-Barrel in Microsomal Triglyceride Transfer Protein Function.	APOB MTTP	7.10e-05	3	170	2	26224785
Pubmed	Plakins: a family of versatile cytolinker proteins.	PPL PLEC	7.10e-05	3	170	2	11854008
Pubmed	Vertebrate nonmuscle myosin II isoforms rescue small interfering RNA-induced defects in COS-7 cell cytokinesis.	MYH10 MYH14	7.10e-05	3	170	2	15774463
Pubmed	Oversulfated chondroitin sulfate plays critical roles in the neuronal migration in the cerebral cortex.	UST CHST15	7.10e-05	3	170	2	18819920
Pubmed	PIASxα ligase enhances SUMO1 modification of PTEN protein as a SUMO E3 ligase.	PTEN PIAS2	7.10e-05	3	170	2	24344134
Pubmed	Lowering plasma cholesterol levels halts progression of aortic valve disease in mice.	APOB MTTP	7.10e-05	3	170	2	19433756
Pubmed	Apolipoprotein B-related gene expression and ultrastructural characteristics of lipoprotein secretion in mouse yolk sac during embryonic development.	APOB MTTP	7.10e-05	3	170	2	10553000
Pubmed	Integrin-independent role of CalDAG-GEFI in neutrophil chemotaxis.	ITGB2 RASGRP2	7.10e-05	3	170	2	20413728
Pubmed	Evolution of sarcomeric myosin heavy chain genes: evidence from fish.	MYH7B MYH15	7.10e-05	3	170	2	15014174
Pubmed	Plasma cholesterol-induced lesion networks activated before regression of early, mature, and advanced atherosclerosis.	APOB MTTP	7.10e-05	3	170	2	24586211
Pubmed	Conditional hepatocyte ablation of PDIA1 uncovers indispensable roles in both APOB and MTTP folding to support VLDL secretion.	APOB MTTP	7.10e-05	3	170	2	38211723
Pubmed	Thiocyanate modulates the catalytic activity of mammalian peroxidases.	MPO EPX	7.10e-05	3	170	2	15894800
Pubmed	Identification and characterization of nonmuscle myosin II-C, a new member of the myosin II family.	MYH10 MYH14	7.10e-05	3	170	2	14594953
Pubmed	Complex genetic architecture in severe hypobetalipoproteinemia.	APOB MTTP	7.10e-05	3	170	2	29540175
Pubmed	Novel mutations of the ABCA12, KRT1 and ST14 genes in three unrelated newborns showing congenital ichthyosis.	KRT1 ABCA12	7.10e-05	3	170	2	35964051
Pubmed	Myeloperoxidase delays neutrophil apoptosis through CD11b/CD18 integrins and prolongs inflammation.	MPO ITGB2	7.10e-05	3	170	2	18617697
Pubmed	ApoB100-LDL acts as a metabolic signal from liver to peripheral fat causing inhibition of lipolysis in adipocytes.	APOB MTTP	7.10e-05	3	170	2	19020660
Pubmed	The eosinophil peroxidase gene forms a cluster with the genes for myeloperoxidase and lactoperoxidase on human chromosome 17.	MPO EPX	7.10e-05	3	170	2	10828600
Pubmed	Characterization of three full-length human nonmuscle myosin II paralogs.	MYH10 MYH14	7.10e-05	3	170	2	24072716
Pubmed	Vascular function during prolonged progression and regression of atherosclerosis in mice.	APOB MTTP	7.10e-05	3	170	2	23307875
Pubmed	Microsomal triglyceride transfer protein expression during mouse development.	APOB MTTP	7.10e-05	3	170	2	10744773
Pubmed	Eliminating atherogenesis in mice by switching off hepatic lipoprotein secretion.	APOB MTTP	7.10e-05	3	170	2	12628954
Pubmed	Disease-associated mutations and alternative splicing alter the enzymatic and motile activity of nonmuscle myosins II-B and II-C.	MYH10 MYH14	7.10e-05	3	170	2	15845534
Cytoband	17q23.1	MPO EPX RNFT1	2.70e-05	16	170	3	17q23.1
GeneFamily	Myosin heavy chains	MYH10 MYH7B MYH14 MYH15	2.23e-06	15	118	4	1098
GeneFamily	Copines	CPNE8 CPNE9 CPNE1	2.21e-05	9	118	3	829
GeneFamily	Phospholipases\|C2 domain containing phospholipases	PLCL2 PLCB4 PLCG1	2.43e-04	19	118	3	832
GeneFamily	C2 tensin-type domain containing\|PTEN protein phosphatases\|Phosphoinositide phosphatases	TPTE2 PTEN	4.17e-04	5	118	2	902
GeneFamily	EF-hand domain containing\|Plakins	PPL PLEC	1.15e-03	8	118	2	939
GeneFamily	DNAJ (HSP40) heat shock proteins\|C2 tensin-type domain containing	TPTE2 PTEN	1.15e-03	8	118	2	837
GeneFamily	CD molecules\|Integrin beta subunits	ITGB2 ITGB7	1.48e-03	9	118	2	1159
GeneFamily	Mannosyl-glycoprotein N-acetylglucosaminyltransferases	MGAT4B MGAT1	1.48e-03	9	118	2	435
GeneFamily	Chloride voltage-gated channels	CLCN3 CLCN5	1.84e-03	10	118	2	302
GeneFamily	Neuropeptide receptors	NPSR1 NPFFR2	1.84e-03	10	118	2	854
GeneFamily	Beta-gamma crystallins	CRYBA1 CRYBB1	4.20e-03	15	118	2	1359
Coexpression	GSE8678_IL7R_LOW_VS_HIGH_EFF_CD8_TCELL_UP	RDM1 ITGB2 PPL SMPDL3B CLCN5 ENTPD1 MTTP PLEC RASGRP2	6.43e-06	199	170	9	M5769
ToppCell	LA-02._Fibroblast_II\|LA / Chamber and Cluster_Paper	COL6A3 DDR2 LAMA2 EBF1 UST SCN7A NAV1 SSH2 TNXB	6.20e-08	194	170	9	234d1494c114cce77c619708bbcd8d5ce805f19b
ToppCell	nucseq-Mesenchymal-Fibroblastic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL6A3 MYH10 DDR2 LAMA2 EBF1 RYR2 CCN5 SCN7A TNXB	6.77e-08	196	170	9	7d8505dac15fa59935ccf592afc54b04c4c6554f
ToppCell	IPF-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	COL6A3 MYH10 LAMA2 DNAH14 RYR2 TENM4 ENTPD1 SCN7A PLCB4	7.07e-08	197	170	9	f304d42fc4936fe20996e07c8dccc698a6e5e5ef
ToppCell	Adult-Mesenchymal\|Adult / Lineage, Cell type, age group and donor	COL6A3 MYH10 DDR2 LAMA2 EBF1 RYR2 CCN5 SCN7A TNXB	7.38e-08	198	170	9	26e55b409db2a1637c95fae7c54b0abea1ef550c
ToppCell	nucseq-Mesenchymal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL6A3 MYH10 DDR2 LAMA2 EBF1 RYR2 CCN5 SCN7A TNXB	7.38e-08	198	170	9	8f52243ca8b9ba68a75ae411506a3a6de258eb97
ToppCell	Fibroblasts\|World / lung cells shred on cell class, cell subclass, sample id	COL6A3 MYH10 DDR2 LAMA2 EBF1 RYR2 CCN5 SCN7A TNXB	7.71e-08	199	170	9	e2b6752fcabd5249a166486ae6796f2c97c1fcaf
ToppCell	5'-Adult-Appendix-Hematopoietic-T_cells-CX3CR1+_CD8_Tmem\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL6A3 ITGB2 CEMIP2 PTCD1 TAP1 SPATA4 ARAP2 RASGRP2	3.99e-07	176	170	8	6b06da40eb97ea2db09f3a769494738b3e5fe3fa
ToppCell	LA-01._Fibroblast_I\|LA / Chamber and Cluster_Paper	COL6A3 DDR2 LAMA2 EBF1 UST SCN7A NAV1 TNXB	4.54e-07	179	170	8	dcb6ec9ae72b13fe388b72dace2815293fafe8ee
ToppCell	human_hepatoblastoma-Tumor_cells-T6\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	MYH7B HTRA4 UST RYR2 CEMIP2 ENTPD1 PLCL2 PLCB4	4.54e-07	179	170	8	14fc8ccb6b215063d747643f47d780d2b237eb67
ToppCell	COVID-19-Heart-Fib_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	COL6A3 DDR2 LAMA2 EBF1 TENM4 SCN7A NAV1 TNXB	5.83e-07	185	170	8	8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell-D231\|Adult / Lineage, Cell type, age group and donor	COL6A3 CTTNBP2 DDR2 LAMA2 EBF1 CCN5 NAV1 TNXB	5.83e-07	185	170	8	fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	OGFR REL LRP1B RYR2 TENM4 NAV1 MYH15 PLEC	6.07e-07	186	170	8	23b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCell	Control-Fibroblasts\|Control / group, cell type (main and fine annotations)	COL6A3 MYH10 DDR2 LAMA2 EBF1 RYR2 SCN7A TNXB	7.13e-07	190	170	8	3a42a9b98d954685d38a741f44545898d0e3e9ce
ToppCell	P07-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	CPNE8 PTGS1 CEMIP2 ENTPD1 ADAMTS18 PLCB4 PLEC RASD2	7.13e-07	190	170	8	e1b721bb74561fe51c53328a0394c9954e489049
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	KRT1 COL6A3 DDR2 LAMA2 EBF1 UST NAV1 TNXB	8.34e-07	194	170	8	c49f72441b3557e2c3a9c4239e68c0cf0652814b
ToppCell	COVID-19-Heart-Fib_1\|Heart / Disease (COVID-19 only), tissue and cell type	COL6A3 DDR2 LAMA2 EBF1 UST TENM4 SCN7A TNXB	8.67e-07	195	170	8	f423baa36ac7cdc383c033e35a7d17e6bf913323
ToppCell	RV-02._Fibroblast_II\|World / Chamber and Cluster_Paper	COL6A3 DDR2 LAMA2 EBF1 PTEN UST SCN7A SSH2	8.67e-07	195	170	8	ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D122\|Adult / Lineage, Cell type, age group and donor	COL6A3 MYH10 DDR2 LAMA2 EBF1 RYR2 CCN5 SCN7A	8.67e-07	195	170	8	aa0add081881d349099d12efca5cdee098038d4e
ToppCell	LA-02._Fibroblast_II\|World / Chamber and Cluster_Paper	COL6A3 DDR2 LAMA2 EBF1 UST SCN7A NAV1 TNXB	8.67e-07	195	170	8	a78b605b49acd8c9d68716266ca269dafcd910b9
ToppCell	Children_(3_yrs)-Mesenchymal\|Children_(3_yrs) / Lineage, Cell type, age group and donor	COL6A3 MYH10 DDR2 LAMA2 EBF1 RYR2 SCN7A TNXB	9.01e-07	196	170	8	bc94909f9b2dc08a59eef1914148b69720569c8f
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A3 MYH10 DDR2 LAMA2 RYR2 CCN5 SCN7A TNXB	9.01e-07	196	170	8	9737a5f006d37b549f281e1863aca558e1e4dc99
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A3 MYH10 DDR2 LAMA2 RYR2 CCN5 SCN7A TNXB	9.01e-07	196	170	8	cecf82cd5e0a3835d655f5e7478578674a63ce25
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL6A3 MYH10 LAMA2 RYR2 CCN5 TENM4 SCN7A TNXB	9.36e-07	197	170	8	6d0d68d460243a0259ada93ebda40fa7b3088eeb
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A3 MYH10 DDR2 LAMA2 RYR2 CCN5 SCN7A TNXB	9.36e-07	197	170	8	94a9603cbd3516fbcce871909693b88f20d41713
ToppCell	cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL6A3 MYH10 DDR2 LAMA2 RYR2 CCN5 SCN7A TNXB	9.72e-07	198	170	8	f1374f7a50244d59c766ac41f44c08c9117407d2
ToppCell	Mesenchymal\|World / Lineage, Cell type, age group and donor	COL6A3 MYH10 DDR2 LAMA2 EBF1 RYR2 SCN7A TNXB	1.01e-06	199	170	8	4bac110c2b3609f6ee5d0e3275da0824a6240270
ToppCell	cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL6A3 MYH10 DDR2 LAMA2 RYR2 CCN5 SCN7A TNXB	1.01e-06	199	170	8	66a79732caf2f04c09b4d9832377aa01ca477677
ToppCell	normal_Lung-Fibroblasts\|normal_Lung / Location, Cell class and cell subclass	COL6A3 MYH10 DDR2 LAMA2 EBF1 CCN5 SCN7A TNXB	1.05e-06	200	170	8	803cf7f1382d07220249029cd220233232027689
ToppCell	Bronchial-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL6A3 MYH10 DDR2 LAMA2 EBF1 RYR2 SCN7A TNXB	1.05e-06	200	170	8	389cc775c8419d90fb77cd794376d2160a7bf44e
ToppCell	3'-Parenchyma_lung-Mesenchymal\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A3 MYH10 DDR2 LAMA2 EBF1 CCN5 SCN7A TNXB	1.05e-06	200	170	8	ba5ed66b05caa1be0bbf8d54c4e72a782b8d9833
ToppCell	Parenchymal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL6A3 MYH10 DDR2 LAMA2 EBF1 RYR2 SCN7A TNXB	1.05e-06	200	170	8	cf433f9b43d7db07acaf70e060f8f77c974e72f3
ToppCell	5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL6A3 DDR2 LAMA2 EBF1 PPL CCN5 PITX1 TNXB	1.05e-06	200	170	8	a2bb67a06757f19be3f56f8cb5bb7e2affa5f4ed
ToppCell	Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-3\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	COL6A3 MYH10 DDR2 LAMA2 RDM1 CCN5 TENM4 SCN7A	1.05e-06	200	170	8	343fa6ba1f52d816d2e41466f674ff8360aecd81
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL6A3 DDR2 LAMA2 EBF1 CCN5 SCN7A NAV1 TNXB	1.05e-06	200	170	8	0c25d56292b9e5fefa4521b72635449be1ffd6fe
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-3-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	COL6A3 MYH10 DDR2 LAMA2 RDM1 CCN5 TENM4 SCN7A	1.05e-06	200	170	8	d0c00cdd52c2e001aec9b935f4e981ba77d0386a
ToppCell	cellseq-Mesenchymal\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL6A3 MYH10 DDR2 LAMA2 EBF1 CCN5 SCN7A TNXB	1.05e-06	200	170	8	238285fc372ce2e5e4341fc3084a3a833bf4a0a6
ToppCell	5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL6A3 DDR2 LAMA2 EBF1 PPL CCN5 PITX1 TNXB	1.05e-06	200	170	8	10f0c20ba7c71d9e2e177597f85b41cb40f0d878
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL6A3 MYH10 DDR2 LAMA2 EBF1 RYR2 SCN7A TNXB	1.05e-06	200	170	8	cae972324d1dfea6efeaf6013f265c7c6bb48db4
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL6A3 MYH10 DDR2 LAMA2 EBF1 RYR2 SCN7A TNXB	1.05e-06	200	170	8	311fab076f2ceb258e3970eb21e39344b894042a
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-3\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	COL6A3 MYH10 DDR2 LAMA2 RDM1 CCN5 TENM4 SCN7A	1.05e-06	200	170	8	07641f476cb1a131c2a50258b88cc13bb38c8379
ToppCell	Adult-Mesenchymal-chondrocyte\|Adult / Lineage, Cell type, age group and donor	COL6A3 MYH10 DDR2 LAMA2 RYR2 CRYBB1 TNXB	2.67e-06	159	170	7	3f7305ee76447064b5c846c4f576360a2f7e0b7c
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_prolif\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CPNE8 CEMIP2 DDX50 ADAMTS18 PLCB4 ZMYM4 BORA	4.00e-06	169	170	7	f086b50791e1c93e253eb5e8d6c4bf617b1416c3
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DDR2 EBF1 LRP1B RYR2 NPFFR2 ADAMTS18 PLCB4	4.16e-06	170	170	7	5570c0e825bca77613bf0ebde620cf744fa1cb84
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A3 MYH10 LAMA2 CCN5 MTTP ACSM5 TNXB	5.04e-06	175	170	7	1799a7be623dc3bf53ba580a7c47d2619969d708
ToppCell	343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-\|343B / Donor, Lineage, Cell class and subclass (all cells)	COL6A3 DDR2 LAMA2 LRP1B NRXN2 SCN7A TNXB	5.23e-06	176	170	7	2e94bbe17c0bb65dc58b4ebc0cb829258bd7373b
ToppCell	343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)\|343B / Donor, Lineage, Cell class and subclass (all cells)	COL6A3 DDR2 LAMA2 LRP1B NRXN2 SCN7A TNXB	5.23e-06	176	170	7	f33ab41d121b59d871ad7d48ca021524a027d2ef
ToppCell	cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	LRP1B PTGS1 RYR2 CCN5 CDH22 MTTP RASD2	5.63e-06	178	170	7	8ec2a25dda96c9cc9c2904b6cb18f75a293f4969
ToppCell	cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	LRP1B PTGS1 RYR2 CCN5 CDH22 MTTP RASD2	5.63e-06	178	170	7	6c91331196696e0cf239d105f458e3230659fa38
ToppCell	droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CPNE8 PTGS1 CEMIP2 CELSR1 ENTPD1 DISP2 RASD2	6.28e-06	181	170	7	cef034030e6b029a49ae56be37ea1fac1a5c350e
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A3 CTTNBP2 LAMA2 APOB RYR2 CCN5 TNXB	6.28e-06	181	170	7	b116c68393d8836bac080f81a8fcbeb52e0403e7
ToppCell	COVID-19-Heart-Fib_+_EC_+_Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	COL6A3 LAMA2 EBF1 TENM4 SCN7A NAV1 TNXB	6.51e-06	182	170	7	fbd5e332df73bf7141c822fa67b76367dc962017
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A3 MYH10 DDR2 LAMA2 RYR2 SCN7A TNXB	7.51e-06	186	170	7	5473283fb95cee556b1f6934cf72169b676b5bcc
ToppCell	facs-Skin-Anagen-3m-Epithelial-nan\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KRT1 ABCA12 DDR2 PTGS1 PPL CELSR1 SLC16A1	7.51e-06	186	170	7	9a7932d0a208f3997216bd21a72913cc82b59fc9
ToppCell	LA-01._Fibroblast_I\|World / Chamber and Cluster_Paper	COL6A3 DDR2 LAMA2 EBF1 UST SCN7A TNXB	7.78e-06	187	170	7	4ea486991f66c29728d127171a07b81404ec0b78
ToppCell	Control-Fibroblasts-Other_FB\|Control / group, cell type (main and fine annotations)	COL6A3 MYH10 LAMA2 RYR2 TENM4 SCN7A TNXB	7.78e-06	187	170	7	bd3739c4a52aa1ba5deffd778e113a9800f7e158
ToppCell	COVID-19-Heart-Fib_1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	COL6A3 DDR2 LAMA2 EBF1 TENM4 SCN7A TNXB	8.05e-06	188	170	7	fe361215f4ba841aa5e1e581fb56f2f4d3ccd201
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 DDR2 LAMA2 EBF1 UST CCN5 TNXB	8.05e-06	188	170	7	ce85a56ac27a6432421dde93a1bafa8b943244b9
ToppCell	Control-Fibroblasts-Adventitial_FB\|Control / group, cell type (main and fine annotations)	COL6A3 DDR2 LAMA2 EBF1 CCN5 SCN7A TNXB	8.05e-06	188	170	7	706a26c372add839d947749f0521a0e1f5c9b0ec
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 DDR2 LAMA2 EBF1 PTEN CHST15 TNXB	8.33e-06	189	170	7	71397e993a77d70b2eeede240bdfc7660b558987
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 DDR2 LAMA2 EBF1 PTEN CHST15 TNXB	8.33e-06	189	170	7	4eea4759520c312bd17a681034d8074e47093d2b
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell-D175\|Adult / Lineage, Cell type, age group and donor	COL6A3 DDR2 LAMA2 EBF1 CCN5 NAV1 TNXB	8.63e-06	190	170	7	7dcca3469f3a3b70db0420cb94f7765f39492f06
ToppCell	LV-01._Fibroblast_I\|World / Chamber and Cluster_Paper	COL6A3 DDR2 LAMA2 EBF1 SCN7A SSH2 TNXB	8.63e-06	190	170	7	12992ec80a7b4f4f17de693f0719ee061a9918fd
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 DDR2 LAMA2 EBF1 UST CHST15 TNXB	8.93e-06	191	170	7	a6c57627077fa980b7ec1d3894b5f31bfb11b738
ToppCell	ASK454-Mesenchymal\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	COL6A3 MYH10 DDR2 LAMA2 RYR2 CCN5 SCN7A	8.93e-06	191	170	7	e30ae7a12439f8a79820b13f03e822c1223fd0cb
ToppCell	LV-02._Fibroblast_II\|World / Chamber and Cluster_Paper	COL6A3 DDR2 LAMA2 EBF1 SCN7A SSH2 TNXB	8.93e-06	191	170	7	d36565257ccba8c1bbed2c1c01be66a9cbb5f834
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 LRRC38 DDR2 LAMA2 EBF1 CCN5 TNXB	8.93e-06	191	170	7	2c51850f5c559d665b8a27a12b75af9ed58dffe1
ToppCell	ASK440-Mesenchymal\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	MPO COL6A3 MYH10 DDR2 LAMA2 CCN5 SCN7A	8.93e-06	191	170	7	f12959eebb4167e1aa03de05d7711a702c58b3c9
ToppCell	ASK454-Mesenchymal-Fibroblast\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	COL6A3 MYH10 DDR2 LAMA2 RYR2 CCN5 SCN7A	8.93e-06	191	170	7	1726add3f392a061536b7aff72ba84303f4a0b1f
ToppCell	RV-01._Fibroblast_I\|World / Chamber and Cluster_Paper	COL6A3 DDR2 LAMA2 EBF1 UST SCN7A SSH2	8.93e-06	191	170	7	70c067c54084bfb02c29bab085f4defd477194fb
ToppCell	ASK440-Mesenchymal-Fibroblast\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	MPO COL6A3 MYH10 DDR2 LAMA2 CCN5 SCN7A	8.93e-06	191	170	7	387296b5377ef6839f0812e5b3529a10b5f7d530
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 DDR2 LAMA2 EBF1 UST CHST15 TNXB	8.93e-06	191	170	7	8f6d592edc32fdb901af30501d4360512334e8c2
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 DDR2 LAMA2 EBF1 PTEN CHST15 TNXB	9.23e-06	192	170	7	bc84b9ce01b4d826a682842ab8a395dac9b91183
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 DDR2 LAMA2 EBF1 PTEN CHST15 TNXB	9.23e-06	192	170	7	5105e4b577408b4e1a62d0a44c23c2b830ccad88
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	COL6A3 DENND4A DOCK9 RNF213 CEMIP2 HERC1 ARAP2	9.23e-06	192	170	7	47646d7e4990be85072987f92bf18d52f8da752e
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 DDR2 LAMA2 EBF1 UST SCN7A TNXB	9.23e-06	192	170	7	beac6b3c191b11add8e39e8d04562b478ea8929e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 DDR2 LAMA2 EBF1 PTEN CHST15 TNXB	9.23e-06	192	170	7	0ab1176cfbb0de8dd1f22c6e2c41265cf6c10ee1
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 DDR2 LAMA2 EBF1 PTEN CHST15 TNXB	9.23e-06	192	170	7	d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a
ToppCell	RV-01._Fibroblast_I\|RV / Chamber and Cluster_Paper	COL6A3 DDR2 LAMA2 EBF1 UST SCN7A TNXB	9.23e-06	192	170	7	356160b113c3305a61ceeaff33ce3c9da0be2878
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A3 MYH10 DDR2 LAMA2 CCN5 SCN7A TNXB	9.23e-06	192	170	7	c5f8e766453f87847b740d6988c524b3d0ef3765
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell\|Adult / Lineage, Cell type, age group and donor	COL6A3 DDR2 LAMA2 EBF1 CCN5 NAV1 TNXB	9.23e-06	192	170	7	d21f0f577156f17c899b08871046a26b88aea011
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	COL6A3 MYH10 DDR2 LAMA2 RYR2 SCN7A TNXB	9.55e-06	193	170	7	b3ad5ff480d99217f36cc7471e5a96a519ddb409
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D231\|Adult / Lineage, Cell type, age group and donor	COL6A3 MYH10 DDR2 LAMA2 RYR2 SCN7A TNXB	9.55e-06	193	170	7	ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a
ToppCell	RV-02._Fibroblast_II\|RV / Chamber and Cluster_Paper	COL6A3 DDR2 LAMA2 EBF1 SCN7A SSH2 TNXB	9.88e-06	194	170	7	11c79a8c56ece42713b04b321982e41e239f07a5
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 DDR2 LAMA2 EBF1 PTEN CHST15 TNXB	9.88e-06	194	170	7	81713e0409e8be695ba5dfdc67a997b33435dd9e
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	COL6A3 MYH10 LAMA2 RYR2 CCN5 SCN7A TNXB	9.88e-06	194	170	7	e93de9428c986b8943fc169258847c650cfab0e5
ToppCell	COVID-19-Heart-Fib_2\|Heart / Disease (COVID-19 only), tissue and cell type	COL6A3 DDR2 LAMA2 EBF1 TENM4 SCN7A TNXB	9.88e-06	194	170	7	d91c9f2ec47319051fc398320693fddbe8bbd4d6
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 DDR2 LAMA2 EBF1 PTEN CHST15 TNXB	9.88e-06	194	170	7	627cffe2d448e74fc5df92e74e5b922a73304137
ToppCell	Control-Fibroblasts-Intermediate_pathological_FB\|Control / group, cell type (main and fine annotations)	COL6A3 MYH10 DDR2 LAMA2 RYR2 TENM4 SCN7A	9.88e-06	194	170	7	03a269f75a481ea54aea8e6444605db8d6df493d
ToppCell	LV-02._Fibroblast_II\|LV / Chamber and Cluster_Paper	COL6A3 DDR2 LAMA2 EBF1 SCN7A SSH2 TNXB	9.88e-06	194	170	7	014d2feb5db2a6a35ef759761a41e466e108c3c1
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 DDR2 LAMA2 EBF1 PTEN CHST15 TNXB	9.88e-06	194	170	7	cf0244a29934e515446ac917d3c30672b460fb04
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 DDR2 LAMA2 EBF1 PTEN CHST15 TNXB	9.88e-06	194	170	7	e03ba6caed59fa64d4d9b042593469d4a6a3dc10
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 DDR2 LAMA2 EBF1 PTEN CHST15 TNXB	9.88e-06	194	170	7	ba7f971fb9a19423602da60770f23d9fead4a451
ToppCell	ASK428-Mesenchymal\|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq	COL6A3 MYH10 DDR2 LAMA2 MUC12 CCN5 SCN7A	1.02e-05	195	170	7	2b156163975d9a3d3fda1402acd9831d0fdc9e25
ToppCell	COVID-19-Fibroblasts-Alveolar_FB\|COVID-19 / group, cell type (main and fine annotations)	COL6A3 MYH10 CTTNBP2 LAMA2 RYR2 SCN7A TNXB	1.02e-05	195	170	7	603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7
ToppCell	RA-02._Fibroblast_II\|RA / Chamber and Cluster_Paper	COL6A3 DDR2 LAMA2 EBF1 UST SCN7A NAV1	1.02e-05	195	170	7	6a02ebbeb3199447ddce64d92d8809436e040eba
ToppCell	ASK428-Mesenchymal-Fibroblast\|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq	COL6A3 MYH10 DDR2 LAMA2 MUC12 CCN5 SCN7A	1.02e-05	195	170	7	c269c0d894a0f55da6495b59d4b9abb9f68df684
ToppCell	facs-Bladder-nan-3m-Epithelial-bladder_cell\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 MYH10 DDR2 LAMA2 PITX1 NAV1 TNXB	1.02e-05	195	170	7	223f5f07dc28fa13a09bb589884c58043c7928c7
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A3 MYH10 LAMA2 RYR2 CCN5 SCN7A TNXB	1.02e-05	195	170	7	df409f94f4e83be89f7a608058ee07ce3ce3a149
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell\|Adult / Lineage, Cell type, age group and donor	COL6A3 MYH10 DDR2 LAMA2 RYR2 SCN7A TNXB	1.02e-05	195	170	7	61c9e09fc84d1012e472185d70ad0a06cee30d6e
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A3 MYH10 LAMA2 RYR2 CCN5 SCN7A TNXB	1.02e-05	195	170	7	4243190ad291d56694e2155954dbaa879c9d3844
Drug	Reactive Black 5	MPO KRT1 EPX MX1	3.59e-07	9	169	4	CID005360531
Drug	AC1L2O1K	MPO EPX PTGS1	1.60e-06	4	169	3	CID000125126
Drug	Azaguanine-8 [134-58-7]; Down 200; 26.2uM; MCF7; HT_HG-U133A	PRRG1 RNGTT WDR7 PPL LGALS3BP MTMR11 PITX1 RNFT1 PLEC ZMYM4	2.07e-06	195	169	10	7444_DN
Drug	AC1L8YWB	MPO EPX GNL3 MX1	4.97e-06	16	169	4	CID000435142
Drug	bromamine	MPO KRT1 EPX	7.90e-06	6	169	3	CID000123346
Drug	geldanamycin; Down 200; 1uM; PC3; HT_HG-U133A	OGFR POLE2 ERN2 MSH6 ENTPD1 PITX1 RNFT1 MYH15 PLCG1	1.29e-05	190	169	9	4452_DN
Drug	N-(carboxyheptyl)maleimide	MPO EPX PTGS1	1.38e-05	7	169	3	CID000092656
Drug	benzidinediimine	MPO EPX PTGS1	1.38e-05	7	169	3	CID000115267
Drug	ethyl hydroperoxide	MPO KRT1 EPX PTGS1	1.59e-05	21	169	4	CID000062472
Drug	Dorzolamide hydrochloride [130693-82-2]; Down 200; 11uM; MCF7; HT_HG-U133A	MAN2C1 ZMYND8 ERN2 PIAS2 RYR2 SLC3A1 CLCN5 ENTPD1 RNFT1	1.79e-05	198	169	9	3565_DN
Drug	8-isoprostaglandin E1	MPO POLE2 APOB ITGB2 PTGS1 ADRA2B ENTPD1 PLCB4 PLCG1 GNL3	1.91e-05	251	169	10	CID000000214
Drug	bityrosine	MPO APOB EPX GADD45GIP1 CRYBA1 CRYBB1	2.35e-05	77	169	6	CID000107904
Disease	Dent disease (implicated_via_orthology)	CLCN3 CLCN5	9.63e-05	3	168	2	DOID:0050699 (implicated_via_orthology)
Disease	creatine kinase measurement, protein measurement	CPN1 CPNE1	9.63e-05	3	168	2	EFO_0004534, EFO_0004747
Disease	muscular dystrophy (is_implicated_in)	COL6A3 FKRP LAMA2	1.16e-04	17	168	3	DOID:9884 (is_implicated_in)
Disease	myeloperoxidase measurement	MPO TAF5L TNXB	4.28e-04	26	168	3	EFO_0005243
Disease	interleukin-27 measurement	CPN1 CPNE1	4.76e-04	6	168	2	EFO_0010916
Disease	liver enzyme measurement, serum alanine aminotransferase measurement	CPN1 CPNE1	4.76e-04	6	168	2	EFO_0004582, EFO_0004735
Disease	aortic measurement	COL6A3 MYH10 RYR2 ENTPD1 NAV1 ADAMTS18 DISP2	6.13e-04	251	168	7	EFO_0020865
Disease	total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer	ABCA12 APOB PLCG1 MX1	6.57e-04	69	168	4	EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004340, EFO_0004348, EFO_0004352, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928, MONDO_0004992
Disease	protocadherin alpha-7 measurement	CPN1 CPNE1	6.64e-04	7	168	2	EFO_0801973
Disease	osteopetrosis (implicated_via_orthology)	CLCN3 CLCN5	6.64e-04	7	168	2	DOID:13533 (implicated_via_orthology)
Disease	Colorectal Carcinoma	MPO RELCH ATP7B ACACA ABCA12 APOB PTEN MSH6 CDH22 VPS13A ADAMTS18 ZMYM4	7.26e-04	702	168	12	C0009402
Disease	muscular dystrophy-dystroglycanopathy type B1 (implicated_via_orthology)	B4GAT1 FKRP	8.82e-04	8	168	2	DOID:0050588 (implicated_via_orthology)
Disease	interleukin 27 receptor subunit alpha measurement	CPN1 CPNE1	8.82e-04	8	168	2	EFO_0008183
Disease	calpastatin measurement	CPN1 CPNE1	8.82e-04	8	168	2	EFO_0008065
Disease	Intellectual Disability	GRIN2D PTEN MFSD2A ADRA2B KARS1 KCNA2 NRXN2 ENTPD1 NT5C2	1.10e-03	447	168	9	C3714756
Disease	protein FAM163B measurement	CPN1 CPNE1	1.13e-03	9	168	2	EFO_0802936
Disease	Profound Mental Retardation	PTEN MFSD2A ADRA2B KCNA2 ENTPD1	1.23e-03	139	168	5	C0020796
Disease	Mental Retardation, Psychosocial	PTEN MFSD2A ADRA2B KCNA2 ENTPD1	1.23e-03	139	168	5	C0025363
Disease	Mental deficiency	PTEN MFSD2A ADRA2B KCNA2 ENTPD1	1.23e-03	139	168	5	C0917816
Disease	autosomal dominant hyaline body myopathy (implicated_via_orthology)	MYH7B MYH15	1.41e-03	10	168	2	DOID:0111269 (implicated_via_orthology)
Disease	distal arthrogryposis type 2B3 (implicated_via_orthology)	MYH7B MYH15	1.41e-03	10	168	2	DOID:0111602 (implicated_via_orthology)
Disease	distal arthrogryposis type 1 (implicated_via_orthology)	MYH7B MYH15	1.41e-03	10	168	2	DOID:0111596 (implicated_via_orthology)
Disease	dilated cardiomyopathy 1S (implicated_via_orthology)	MYH7B MYH15	1.41e-03	10	168	2	DOID:0110454 (implicated_via_orthology)
Disease	familial hypercholesterolemia (is_implicated_in)	APOB MTTP	1.41e-03	10	168	2	DOID:13810 (is_implicated_in)
Disease	adseverin measurement	CPN1 CPNE1	1.41e-03	10	168	2	EFO_0801358
Disease	congenital myopathy 6 (implicated_via_orthology)	MYH7B MYH15	1.41e-03	10	168	2	DOID:0080719 (implicated_via_orthology)
Disease	inclusion body myositis (implicated_via_orthology)	MYH7B MYH15	1.41e-03	10	168	2	DOID:3429 (implicated_via_orthology)
Disease	distal arthrogryposis type 2A (implicated_via_orthology)	MYH7B MYH15	1.41e-03	10	168	2	DOID:0111605 (implicated_via_orthology)
Disease	familial hypertrophic cardiomyopathy (implicated_via_orthology)	MYH7B MYH15	1.41e-03	10	168	2	DOID:0080326 (implicated_via_orthology)
Disease	Moyamoya disease	DOCK9 RNF213 SMPDL3B	1.53e-03	40	168	3	MONDO_0016820
Disease	Fatty Liver	ATP7B APOB PTEN MTTP	1.63e-03	88	168	4	C0015695
Disease	Steatohepatitis	ATP7B APOB PTEN MTTP	1.63e-03	88	168	4	C2711227
Disease	Semantic-Pragmatic Disorder	PTEN KCNA2	1.71e-03	11	168	2	C0454655
Disease	cell growth regulator with EF hand domain protein 1 measurement	CPN1 CPNE1	1.71e-03	11	168	2	EFO_0801461
Disease	Auditory Processing Disorder, Central	PTEN KCNA2	1.71e-03	11	168	2	C0751257
Disease	3-hydroxyanthranilate 3,4-dioxygenase measurement	CPN1 CPNE1	1.71e-03	11	168	2	EFO_0021862
Disease	Language Delay	PTEN KCNA2	1.71e-03	11	168	2	C0023012
Disease	Language Development Disorders	PTEN KCNA2	1.71e-03	11	168	2	C0023014
Disease	Speech Delay	PTEN KCNA2	1.71e-03	11	168	2	C0241210
Disease	Long QT Syndrome	PTEN RYR2	1.71e-03	11	168	2	C0023976
Disease	dermatomyositis	CPN1 CPNE1	2.05e-03	12	168	2	EFO_0000398
Disease	Dental enamel hypoplasia	MYH7B MYH14	2.05e-03	12	168	2	EFO_1001304
Disease	distal myopathy (implicated_via_orthology)	MYH7B MYH15	2.05e-03	12	168	2	DOID:11720 (implicated_via_orthology)
Disease	myotonia congenita (implicated_via_orthology)	MYH7B MYH15	2.05e-03	12	168	2	DOID:2106 (implicated_via_orthology)
Disease	Congenital muscular dystrophy	FKRP LAMA2	2.05e-03	12	168	2	cv:C0699743
Disease	attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement	CTTNBP2 LAMA2 RYR2 CEMIP2 MSH6 CDH22 TENM4 NRXN2 PLCL2 HERC1 PLXNA2 ARAP2	2.21e-03	801	168	12	EFO_0003888, EFO_0007052, MONDO_0002491
Disease	restrictive cardiomyopathy (implicated_via_orthology)	MYH7B MYH15	2.41e-03	13	168	2	DOID:397 (implicated_via_orthology)
Disease	gallbladder cancer (is_implicated_in)	APOB LRP1B	2.41e-03	13	168	2	DOID:3121 (is_implicated_in)
Disease	vascular endothelial function measurement	TPCN2 UST PRDM13 TNXB	2.51e-03	99	168	4	EFO_0803369
Disease	smoking status measurement	CPNE8 CTTNBP2 FKRP LAMA2 RYR2 FANCF TENM4 NRXN2 PTCD1 PLCL2 NT5C2 CC2D2A HERC1 PLXNA2 ARAP2	2.69e-03	1160	168	15	EFO_0006527
Disease	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2K	B4GAT1 FKRP	2.80e-03	14	168	2	C1836373
Disease	alpha-Dystroglycanopathies	B4GAT1 FKRP	2.80e-03	14	168	2	C2936406
Disease	Fukuyama Type Congenital Muscular Dystrophy	B4GAT1 FKRP	2.80e-03	14	168	2	C0410174
Disease	Muscle eye brain disease	B4GAT1 FKRP	2.80e-03	14	168	2	C0457133
Disease	Autosomal recessive limb-girdle muscular dystrophy	FKRP PLEC	2.80e-03	14	168	2	cv:C2931907
Disease	renal cell carcinoma (biomarker_via_orthology)	PTEN PTGS1	2.80e-03	14	168	2	DOID:4450 (biomarker_via_orthology)
Disease	Muscular Dystrophy-Dystroglycanopathy (Congenital with Brain and Eye Anomalies) Type A, 1	B4GAT1 FKRP	2.80e-03	14	168	2	C4284790
Disease	Walker-Warburg congenital muscular dystrophy	B4GAT1 FKRP	3.22e-03	15	168	2	C0265221
Disease	glucose homeostasis measurement, glucose effectiveness measurement	MYH7B MYH14	3.22e-03	15	168	2	EFO_0006833, EFO_0006896
Disease	distal arthrogryposis (implicated_via_orthology)	MYH7B MYH15	3.22e-03	15	168	2	DOID:0050646 (implicated_via_orthology)
Disease	granulysin measurement	CPN1 CPNE1	3.22e-03	15	168	2	EFO_0008144
Disease	Malignant neoplasm of breast	PRRG1 MAN2C1 ATP7B B4GAT1 KIF16B LAMA2 GRIN2D PTEN PTGS1 CNTN6 ZNF404 PIK3R4 MSH6 ARRDC3	3.45e-03	1074	168	14	C0006142
Disease	non-alcoholic fatty liver disease, type 2 diabetes mellitus	RNGTT PIGC PTCD1 ADAMTS18	3.66e-03	110	168	4	EFO_0003095, MONDO_0005148
Disease	neutrophil collagenase measurement	CPN1 CPNE1	3.67e-03	16	168	2	EFO_0008248
Disease	calcium/calmodulin-dependent protein kinase type 1 measurement	CPN1 CPNE1	3.67e-03	16	168	2	EFO_0008062
Disease	leukemia	PTEN MSH6 FANCF	3.83e-03	55	168	3	C0023418
Disease	fatty liver disease (is_marker_for)	PTEN MTTP	4.14e-03	17	168	2	DOID:9452 (is_marker_for)
Disease	response to radiation, Urinary retention	COL6A3 LRP1B	4.14e-03	17	168	2	GO_0009314, HP_0000016
Disease	serum alanine aminotransferase measurement	TPCN2 MYH7B KIF16B APOB CPN1 PTEN TENM4 NRXN2 MTTP ADAMTS18 CPNE1 MX1	4.25e-03	869	168	12	EFO_0004735
Disease	cognitive behavioural therapy	COG2 SCN7A NT5C2	4.45e-03	58	168	3	EFO_0007820
Disease	DNA methylation	RNGTT WDR7 ERO1A LRP1B CNTN6 TENM4 ENTPD1 ADAMTS18 PRDM13 ARAP2	4.51e-03	656	168	10	GO_0006306
Disease	Nuclear non-senile cataract	CRYBA1 CRYBB1	4.64e-03	18	168	2	C1112705
Disease	Nuclear cataract	CRYBA1 CRYBB1	4.64e-03	18	168	2	C0392557
Disease	Malignant neoplasm of endometrium	PTEN MSH6	4.64e-03	18	168	2	C0007103
Disease	Carcinoma in situ of endometrium	PTEN MSH6	4.64e-03	18	168	2	C0346191
Disease	creatine kinase measurement	EBF1 CPN1 CPNE1	4.67e-03	59	168	3	EFO_0004534
Disease	Schizophrenia	NPSR1 LAMA2 GRIN2D PTGS1 TENM4 NRXN2 PLCL2 NAV1 TAP1 TNXB PLXNA2 RASD2	4.81e-03	883	168	12	C0036341
Disease	X-11470 measurement	TNXB VARS1	5.17e-03	19	168	2	EFO_0021241
Disease	inflammatory bowel disease (is_implicated_in)	NPSR1 ANO6	5.17e-03	19	168	2	DOID:0050589 (is_implicated_in)
Disease	ankylosing spondylitis (is_implicated_in)	ANO6 TAP1	5.17e-03	19	168	2	DOID:7147 (is_implicated_in)
Disease	renovascular hypertension (biomarker_via_orthology)	MPO LAMA2	5.17e-03	19	168	2	DOID:1591 (biomarker_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
ELNAQYRARFGFPFV	URAD	106	A6NGE7
VEELLRGAQYFNTPR	CCIN	101	Q13939
FDLRIPFARYVARNN	EIF2AK4	1116	Q9P2K8
QYPNKFIQRDDTERF	NT5C2	136	P49902
PTFDERFRQYGFNRI	B4GAT1	336	O43505
GFFRINDQRYLIEPV	ADAM7	131	Q9H2U9
APIQQLADRFSGYFV	ATP7B	911	P35670
VQKVYPRFATNEGFR	ABCA12	296	Q86UK0
LNPFLYVFVGRDFQE	GPR32	311	O75388
GFDQYRALLQEQFRR	ABCF3	691	Q9NUQ8
PGNYRLVVFELENFQ	CRYBB1	56	P53674
GSFYFLELNPRLQVE	ACACA	431	Q13085
LNPVIYTIFNQDFRR	ADRA2B	421	P18089
AISLGRQLVPEYFNF	ACSM5	41	Q6NUN0
FNIIGAFDIPRFVYN	POLE2	86	P56282
IFPYGETFLFQRLEN	ARAP2	331	Q8WZ64
LEAFRDPQFQGLFQY	AP5Z1	506	O43299
RGQFFPSEDLQEQIY	CELSR1	1271	Q9NYQ6
AEYRQLFLFEQLPQG	DISP2	751	A7MBM2
FERALQGPLFAYIQE	ARRDC3	371	Q96B67
GTTFEYQRSFNRPER	ADAMTS18	816	Q8TE60
LYNPGLEFERQQREE	KIF16B	591	Q96L93
SYNGFPVLRNNLFER	DENND4A	696	Q7Z401
NPIIYGFFNENFRRG	NPFFR2	431	Q9Y5X5
EPSALEQGFRQAYRA	HDHD3	41	Q9BSH5
FEDRINFAVFPSLQG	SHMT2	311	P34897
VFRNGIPYLNQEEER	PARN	126	O95453
QFGLLYSVRVFPNAA	RDM1	41	Q8NG50
FFNDGQRRIDFVLVY	ANO6	61	Q4KMQ2
RLRDYFSNPGNFERQ	RELCH	126	Q9P260
RPRIQYFFAASVVAN	SLC16A1	326	P53985
PLRNEYFFDRNRPSF	KCNA2	71	P16389
LRFNGYRENPNLQED	FANCF	146	Q9NPI8
RSEIRGVDIDNPYFN	LRP1B	1581	Q9NZR2
DFFIRQGRSYRDQQL	LPGAT1	146	Q92604
FNGFRTVIRPFYLTN	LGALS3BP	566	Q08380
LGPRYDSQVAEENRF	RNGTT	31	O60942
ISQEEFQIIRGNFPY	RASGRP2	446	Q7LDG7
RDFLARVYGAPQLQV	MGAT1	356	P26572
FQPLRLERFFFRSGN	MGAT4B	441	Q9UQ53
LDNFNLLPDTQERFY	NPSR1	296	Q6W5P4
DDRRFPDFSYITQNG	INTS11	41	Q5TA45
PLNSEYDFALVNIGR	MTMR11	91	A4FU01
TGEFFRDQGRQTYLP	DDR2	801	Q16832
FNQEPGRLYVELQFF	GPR155	681	Q7Z3F1
QIQFNLLDFTRRAYG	CFAP20	131	Q9Y6A4
GANNPAIRVFEYDRA	SMPDL3B	316	Q92485
DGFVQYFTNRFPRLL	ERN2	876	Q76MJ5
PNATAEVGYNRDRFL	HERC1	4551	Q15751
EVGYNRDRFLFNPSA	HERC1	4556	Q15751
GFPNRILFQEFRQRY	MYH14	731	Q7Z406
QGFPNRLLYTDFRQR	MYH7B	756	A7E2Y1
SNLQFEYIDDPRVQR	PLXNA2	1031	O75051
NLEPYFESFINNLRR	KRT1	226	P04264
FRRLLNFAQTQYGDP	LCTL	391	Q6UWM7
LFDVQLRPVTFFNGY	MTTP	696	P55157
YPDINFNRLFEGRSS	PARG	656	Q86W56
FVYVNPEDGRIFAQR	PCDHGC5	506	Q9Y5F6
QFFAIEIARNREGYN	PBDC1	141	Q9BVG4
LDYPSRRRQYENFIN	PPL	246	O60437
RDIFRANIYPRGFVN	EPX	686	P11678
VDPRIANVFTNAFRY	MPO	486	P05164
NFEESVLNYRFDPLG	FAM214A	881	Q32MH5
VNERYPAGNFDNERL	NRXN2	1246	Q9P2S2
ADFATVQLRNGLPYF	LAMA2	2811	P24043
GEDFYIPRQSVAQRF	MOCOS	301	Q96EN8
NRIQRIPEDFFIFYG	LRRC38	66	Q5VT99
IYQPRGFNESDRLVY	NLRP4	296	Q96MN2
NVPGFFLVRRENPEY	MIEF1	226	Q9NQG6
DPELLFGVQFQYRNR	PTGS1	361	P23219
GRIFAGQNRLYQPEE	PRSS54	366	Q6PEW0
LSNYPFDFQGARIIT	ENTPD1	156	P49961
GIGRNRYQLEIPENF	MSH6	971	P52701
EPQQLQVRFLRAEGY	ITGB7	136	P26010
AQQSEPIAYFRGLRL	MFSD2A	286	Q8NA29
NERYPAGNFDNERLA	NRXN2	201	P58401
AATEREFGNYLFRQN	FKBP6	171	O75344
YLRPGQAAAFNVTFR	ITGB2	106	P05107
DFYPNRFLDDQGQLI	CYP2U1	461	Q7Z449
LPFFETLQEYFERNR	APOB	2071	P04114
GPLRRNYNFIAAVVE	HTRA4	161	P83105
ESYVPDFFRLEQLQQ	CC2D2A	881	Q9P2K1
FNIQRYESPLRINFD	CC2D2A	1441	Q9P2K1
GVDLNRNFPDLNTYI	CPN1	156	P15169
FPYDDFQTAILRRQG	DOCK9	76	Q9BZ29
IQERYGRFNLNDPFL	CTTNBP2	71	Q8WZ74
PVDFNLENILGDYFR	BORA	161	Q6PGQ7
NPFGNSRLVLFYVEF	CLCN5	366	P51795
ANLVGQFPVVRDFLY	COL6A3	846	P12111
VQFVPFRDYVDRSGN	CPNE9	491	Q8IYJ1
FCGQQFILERGEYPR	CRYBA1	81	P05813
FYQPRERGQLRYVEQ	DDX50	491	Q9BQ39
EVNGRLYREGETFQP	CCN5	101	O76076
PRNRTFPIRGFQIYD	CEMIP2	861	Q9UHN6
DNPLYVQEDNRRFVS	CNTN6	161	Q9UQ52
ALNEPTIDYGFQRLQ	EBF1	346	Q9UH73
FPQAFLAAVLQDYGR	DNAH14	3331	Q0VDD8
ETIDRFNNYRLFPRL	ERO1A	51	Q96HE7
YQEAVQRDFRPAQVG	MAN2C1	56	Q9NTJ4
GRDVPLTQYQRDFGL	MAP6D1	61	Q9H9H5
QELLGYQVDPRSARF	GADD45GIP1	161	Q8TAE8
PGYRNSLEFFTVLAQ	GNL3	356	Q9BVP2
FPTARDPQGNYFIDR	KCTD6	46	Q8NC69
GFNRQEQDVFFLPIL	CDH22	566	Q9UJ99
NLPVYFQIRFREIAG	COG2	381	Q14746
GFVAQAPNNYRRFLE	FKRP	456	Q9H9S5
DFEQLPARIQDFLRY	B3GNT6	81	Q6ZMB0
ENIRRKFGVFNYSPF	ZMYND8	351	Q9ULU4
GQIFYRALRDVQPGE	PRDM13	91	Q9H4Q3
LAESVLNYFQPFLGR	RYR2	4121	Q92736
VQFVPFRDYIDRSGN	CPNE8	501	Q86YQ8
FQEFRQRYEILTPNA	MYH10	721	P35580
VQFVPYRRFQNAPRE	CPNE1	481	Q99829
EGNQFRANYFLQPEL	NPHP1	341	O15259
GFPAERLEGVYRNNI	PTEN	36	P60484
DFLPGGRRDYTVQVQ	PIAS2	196	O75928
SERNPYVFNGDFVDR	PPEF1	191	O14829
FYRNEIRFLPNGCFI	OGFR	96	Q9NZT2
GFSDQPQLERFLFAI	OR2G6	16	Q5TZ20
NNVEPANGFLVRYLR	NAV1	1681	Q8NEY1
LQELEATFQRNRYPD	PITX1	101	P78337
RLSNQGFQAYDFPAV	VARS1	996	P26640
EPQQYEVQFGRLRNF	TAF5L	66	O75529
FRNNFGVREPYQILL	UTP23	16	Q9BRU9
QLQRRGFFICDQPYE	EPRS1	671	P07814
NGLNPVYNEESFVFR	PLCB4	746	Q15147
RRCSQPVFEADQFQY	TAGAP	711	Q8N103
LQYQRAGVRFLAPFA	TMEM132A	541	Q24JP5
QAYDVDFTPPFRRIN	KARS1	381	Q15046
ICREGFPNRLQYADF	MYH15	716	Q9Y2K3
PGDFVNYNKRFLARV	PLCL2	661	Q9UPR0
FRQFRYQDAAGPREA	SCAND1	111	P57086
ANPILYGFLSDNFRR	SSTR4	306	P31391
QFLRERLFEASDPYQ	POLR2B	1101	P30876
LFQIVPGENPYRFRD	ST3GAL2	131	Q16842
EVLFQFSGQARYRIP	SLC3A1	71	Q07837
GLVQFQDVSFAYPNR	TAP1	501	Q03518
RQPFPDNYVDRRFLE	PIGC	21	Q92535
LRDFYRPFNARLAQV	CHST15	536	Q7LFX5
INPFGNSRLVLFYVE	CLCN3	366	P51790
QRGNAFPEIFYTFLQ	PIK3R4	311	Q99570
GLDLSFFPRNINRDF	SPATA4	61	Q8NEY3
YQGLLLQRVPFNVDF	RNF213	2351	Q63HN8
NIIRDPVNRFLSNYF	UST	186	Q9Y2C2
RGEQRYPFEALFRSQ	VPS52	371	Q8N1B4
FRQVLRIFFTQPSYG	RNFT1	346	Q5M7Z0
DNPERFYRYNIVLGS	TRIM68	336	Q6AZZ1
ENEFNIPLGSYRSFI	VPS13A	2021	Q96RL7
LDPNAGRFVRYQFTP	UNC119	121	Q13432
YQFTPAFLRLRQVGA	UNC119	131	Q13432
YILNVTREIDNFFPG	SSH2	336	Q76I76
FTPETERQRLQYLAF	PPM1H	306	Q9ULR3
RQFRYQEAAGPQEAL	ZSCAN25	46	Q6NSZ9
QGPFDSFLVQYRDAQ	TNXB	3286	P22105
SRYQQPFEDFRISQE	PLCG1	1251	P19174
VSRFLNGRFEDQYTP	RASD2	36	Q96D21
GDFNYIRRIFPSGNV	TENM4	1246	Q6N022
AEFGQERRPLFFQNL	REL	91	Q04864
ATGFLVDPVRNQRLY	PLEC	3531	Q15149
LEQLESAFGRNQYPD	PROP1	81	O75360
FRTDPQYTIEFGRQQ	ZNF404	86	Q494X3
KRYPRANGFFEEIRQ	PRRG1	16	O14668
NRTGNPYYIRETENF	SCN7A	281	Q01118
RVFVEGRQQYFSDLF	TPTE2	126	Q6XPS3
FSYDGSPRAQIFRRN	PLBD2	451	Q8NHP8
RQLEFAAQYPPTFDR	PTCD1	626	O75127
FYQFSVGNQREGRLL	WDR7	116	Q9Y4E6
GPQFIFEYANELRRS	TRBV5-3	61	A0A0A0MS03
FEYANELRRSEGNFP	TRBV5-3	66	A0A0A0MS03
NGRIDNIFTEPYSRF	ZMYM4	1321	Q5VZL5
GQDRERLTYFQNLPE	TPCN2	246	Q8NHX9
PETFRQLFRLFCYQE	ZNF500	46	O60304
QLFRLFCYQEVAGPR	ZNF500	51	O60304
QPYSFVDNVGFNRLL	ZBED4	671	O75132
ESRFGLENAYNNFRP	MUC12	5441	Q9UKN1
FENQYRGRELPGFVN	MX1	436	P20591
NRDYSFNEDGFLVNP	GRIN2D	371	O15399